Plus Therapeutics (PSTV) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free PSTV Stock Alerts $2.16 0.00 (0.00%) (As of 02:44 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Plus Therapeutics Short Interest DataCurrent Short Volume46,100 sharesPrevious Short Volume46,500 sharesChange Vs. Previous Month-0.86%Dollar Volume Sold Short$80,237.05Short Interest Ratio / Days to Cover0.7Last Record DateApril 30, 2024Outstanding Shares4,280,000 sharesFloat Size4,210,000 sharesShort Percent of Float1.10%Today's Trading Volume32,517 sharesAverage Trading Volume56,770 sharesToday's Volume Vs. Average57% Short Selling Plus Therapeutics ? Sign up to receive the latest short interest report for Plus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPSTV Short Interest Over TimePSTV Days to Cover Over TimePSTV Percentage of Float Shorted Over Time Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here Plus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202446,100 shares $80,237.05 -0.9%1.1%0.7 $1.74 4/15/202446,500 shares $80,910.00 -0.6%1.1%1.5 $1.74 3/31/202446,800 shares $84,474.00 +45.3%1.1%1.5 $1.81 3/15/202432,200 shares $55,706.00 -21.1%0.8%0.9 $1.73 2/29/202440,800 shares $79,152.00 -12.1%1.0%1.1 $1.94 2/15/202446,400 shares $92,336.00 +7.2%1.0%1.2 $1.99 Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202443,300 shares $87,033.00 -25.3%1.0%0.6 $2.01 1/15/202458,000 shares $120,060.00 +21.9%1.3%0.2 $2.07 12/31/202347,600 shares $83,304.76 -26.3%1.1%0.2 $1.75 12/15/202364,600 shares $123,386.00 -25.5%1.5%0.2 $1.91 11/30/202386,700 shares $147,390.00 -59.7%2.0%0.1 $1.70 11/15/2023215,000 shares $406,350.00 +441.6%4.9%0.3 $1.89 10/31/202339,700 shares $48,434.00 -43.8%0.9%0.1 $1.22 10/15/202370,600 shares $97,428.00 -27.6%2.5%0.2 $1.38 9/30/202397,500 shares $130,650.00 -30.6%3.4%0.2 $1.34 9/15/2023140,500 shares $195,295.00 +347.5%5.0%0.3 $1.39 8/31/202331,400 shares $87,606.00 -50.4%1.1%0.1 $2.79 8/15/202363,300 shares $153,819.00 +76.8%2.2%1.5 $2.43 7/31/202335,800 shares $88,068.00 +35.6%1.4%1 $2.46 7/15/202326,400 shares $54,648.00 -13.2%1.1%0.8 $2.07 6/30/202330,400 shares $61,408.00 -24.6%1.2%1 $2.02 6/15/202340,300 shares $122,512.00 -3.8%1.6%1.5 $3.04 5/31/202341,900 shares $168,438.00 -14.3%1.7%1.7 $4.02 5/15/202348,900 shares $213,693.00 +154.7%2.0%1.9 $4.37 4/30/202319,200 shares $74,822.40 -66.6%0.8%0.8 $3.90 4/15/202357,500 shares $15,939.00 -76.7%N/A0.2 $0.28 3/31/2023247,100 shares $71,659.00 -13.8%N/A0.9 $0.29 3/15/2023286,600 shares $80,391.30 +4.1%N/A0.9 $0.28 2/28/2023275,400 shares $93,691.08 -31.4%N/A0.8 $0.34 2/15/2023401,600 shares $156,624.00 -14.9%N/A1.2 $0.39 1/31/2023472,000 shares $204,517.60 +17.2%N/A1.4 $0.43 1/15/2023402,600 shares $192,523.32 +39.7%N/A1.2 $0.48 12/30/2022288,200 shares $91,359.40 -31.9%N/A0.7 $0.32 12/15/2022423,100 shares $132,007.20 -5.0%N/A0.6 $0.31 11/30/2022445,200 shares $179,282.04 -17.8%N/A0.5 $0.40 11/15/2022541,500 shares $234,956.85 -11.4%N/A0.4 $0.43 10/31/2022610,900 shares $287,123.00 -50.3%N/A0.1 $0.47 10/15/20221,230,000 shares $642,060.00 +388.9%N/A0.3 $0.52 9/30/2022251,600 shares $111,962.00 +74.0%N/A0.1 $0.45 9/15/2022144,600 shares $89,565.24 -73.5%N/A0 $0.62Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. PSTV Short Interest - Frequently Asked Questions What is Plus Therapeutics' current short interest? Short interest is the volume of Plus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 46,100 shares of PSTV short. 1.10% of Plus Therapeutics' shares are currently sold short. Learn More on Plus Therapeutics' current short interest. What is a good short interest ratio for Plus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTV shares currently have a short interest ratio of 1.0. Learn More on Plus Therapeutics's short interest ratio. What is a good short interest percentage for Plus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.10% of Plus Therapeutics' floating shares are currently sold short. Is Plus Therapeutics' short interest increasing or decreasing? Plus Therapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 46,100 shares, a drop of 0.9% from the previous total of 46,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Plus Therapeutics' float size? Plus Therapeutics currently has issued a total of 4,280,000 shares. Some of Plus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Plus Therapeutics currently has a public float of 4,210,000 shares. How does Plus Therapeutics' short interest compare to its competitors? 1.10% of Plus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Plus Therapeutics: NeuroMetrix, Inc. (1.04%), ProSomnus, Inc. (1.18%), Vapotherm, Inc. (9.92%), Vivos Therapeutics, Inc. (2.28%), Intelligent Bio Solutions Inc. (3.68%), Biotricity, Inc. (7.35%), PetVivo Holdings, Inc. (1.49%), Avinger, Inc. (1.74%), Microbot Medical Inc. (2.38%), NEXGEL, Inc. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Plus Therapeutics stock? Short selling PSTV is an investing strategy that aims to generate trading profit from Plus Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Plus Therapeutics? A short squeeze for Plus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTV, which in turn drives the price of the stock up even further. How often is Plus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTV, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NeuroMetrix Short Squeeze ProSomnus Short Squeeze Vapotherm Short Squeeze Vivos Therapeutics Short Squeeze Intelligent Bio Solutions Short Squeeze Biotricity Short Squeeze PetVivo Short Squeeze Avinger Short Squeeze Microbot Medical Short Squeeze NEXGEL Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTV) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorObama’s Forever Term [exposed]Porter & CompanyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmith